Clinical Trials

Protocol #	Protocol Name	Status
Cervical Treatment Protocols
G9918	A Phase I Trial of Tailored Radiation Therapy with Concomitant Cetuximab (C225,NSC #714692) and Cisplatin (NSC #714692) in the Treatment of Patients with Cervical Cancer	Open
Uterine/Endometrial Treatment Protocols
G209	Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or recurrent Endometrial Cancer	Open
G210	A Molecular Staging Study of Endometrial Carcinoma	Open
G0087M	A Phase II Evaluation of Trabectedin (Yondelis, R279741, IND#75,111) in the Treatment of Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas	Open
Ovarian Protocols
KTN32313R J07107	A Phase 3 Study of Safety and Efficacy of Karenitecin versus Topotecan Administered for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Epithelial Ovarian Cancer	Open
IP Spore J0741	Pilot Trial of Intraperinteal Paclitaxel and Carboplatin with IV Avastin Therapy in The Treatment of Women with Newly Diagnosed, Optimally Cytoreduced Carcinoma Of Mullerian Origin	Open
G9916	A Phase I Trial of Intravenous Paclitaxel Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel or Intravenous Docetaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel inPatients with Previously Untreated Epithelial Ovarian Carcinoma, Fallopian Tube or Primary Peritoneal Carcinoma	Open
G9917	A Dose-Escalating Phase I Study with an Expanded Cohort to Assess the Feasibility of Intraperitoneal Carboplatin (NSC#214240) and Intravenous Paclitaxel (NSC# 673089) in Patients with Previously Untreated Epithelial Ovarian, Primary Peritoneal,or Fallopian Tube Carcinoma	Open
G218	A Phase III Trial of Carboplatin and Paclitaxel plus placebo versus Carboplatin and Open Paclitaxel Plus Concurrent Bevacizumab (RhuMab VEGF, NSC #704865, IND#7921) followed by placebo, versus Carboplatin and Paclitaxel plus Concurrent and Extended Bevacizumab in Women with Newly Diagnosed, Previously Untreated suboptimal advanced stage Epithelial Ovarian and Peritoneal Primary Cancer	Open
Agensys 2008001	A Phase 1, Open-Label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics Submitted of AGS-8M4 Given as Monotherapy in Subjects with Advanced Ovarian Cancer	Open
Acquisition Protocols
GOG 136	Acquisition of Human Gynecologic Specimens and Serum to be used in Studying the Causes, Diagnosis, Prevention and Treatment of Cancer	Open
Non-Treatment Protocols
J9883	Acquisition of Gynecologic Tissues, Ascites and Serum Specimen	Open
J-0073	Patterns of Ovarian Cancer Surgery in Maryland	Open
04-02-05-10e	To Develop T-cell Based Immunotherapy for the Treatment of Ovarian Cancer	Open
03-03-19-10d	Database of Clinical Information for all Kelly Gynecologic Oncology Service Patients with a Cancer Diagnosis on a Secure, Encrypted Website	Open
04-11-19-01	Comparison of Preoperative VEGF and COX-2 Immunohistochemical Staining With Final Pathologic Diagnosis in Patients Initially Diagnosed with Atypical Endometrial Hyperplasia	Open
NA_00001222	Oncotech Extreme Drug Resistance Assay; the Prognostic Significance of Molecular Regulations on Optimal Cytoreductibility and Chemotherapy Response Prediction in Women with Borderline Tumors of the Ovary and Ovarian Cancer	Open
NA_000001205	Mesenteric Lymph Node Involvement in Patients Undergoing Colorectal Resection for Epithelial Ovarian Cancer	Open
NA_00001185	Clinical Characteristics and Biochemical Markers that Define the Optimal Patients for Hormonal Management of Complex Atypical Hyperplasia and Endometrial Cancer	Open
NA_00001195	The Role of Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Cancer	Open
05-06-30-02	Patterns of Surgical care for Uterine Cancer in MD during 1990-2000: Physicians and Hospital Care Volume	Open
04-07-02-09e	Isolation of Cancer Stem Cells in Epithelial Ovarian Carcinoma (Matsui)	Open
NA_00001982	Surveillance Analysis for Recurrent Ovarian Cancer	Open
NA_00002481	Radical Surgical Procedures to Achieve Optimal Cytoreduction and the Impact on Disease free Interval	Open
NA_00001945	Clinico-Pathological features of Carcinosarcoma (Malignant Mixed Mesodermal Tumors) of the Uterus and Ovary	Open
NA_00002695	Evaluation of Natural Killer T Lymphocytes in Immune Response Against Ovarian Cancer	Open
NA_00002171	Surgical Staging of Borderline Ovarian Tumors	Open
NA_00002959	Clinical value, cost effectiveness and predictive factors of intra-operative findings in Patients with early endometrial cancer as compared to other modalities	Open
NA_00005472	Immuno-Modulating Effects of Ascites	Open
NA_00003653 - J0787	A Multicenter Trial on the Utility and Impact of Computed Tomography and Serum CA-125 in the Management of Newly Diagnosed Ovarian Cancer	Open
NA_00017236	Investigation of the Feasibility of Intravenous Gemcitabine and Cisplatin in the Treatment of Ovarian Cancer	Open
NA_00001040	The Use of Daily Goals Form to Improve Communication in the Gynecologic Oncology Unit.	Open